Log In
Print this Print this

INFINITI Warfarin Assay

  Manage Alerts
Collapse Summary General Information
Company AutoGenomics Inc.
DescriptionAssay that identifies patients with cytochrome P450 2C19 (CYP2C19) and vitamin K epoxide reductase complex subunit 1 (VKORC1)genetic variants
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCardiovascular, Diagnostic
Indication DetailsHelp optimize dosing of warfarin in patients with CYP 450 2C9 and VKORC1 genetic variants; Identify individuals at risk for sensitivity to warfarin
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today